A randomized, double-blind, placebo-controlled, parallel-group study showed that among the patients with T2DM treated with EX monotherapy, EX could improve glycated hemoglobin, fasting blood glucose, and postprandial blood glucose control, reduce weight, improve cell function, and adjust blood pressure
hormone-based metabolic understanding
doi: 10.1073/pnas.100009210 48
Both require weekly injections
It will say 30, 50, or 100
In conclusion, taking advantage of the elevated GSH in TME, our study affords a new strategy for targeted chemotherapy of ATC with high selectivity and reduced adverse effects